1. Home
  2. NWE vs CRNX Comparison

NWE vs CRNX Comparison

Compare NWE & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NorthWestern Energy Group Inc.

NWE

NorthWestern Energy Group Inc.

HOLD

Current Price

$72.13

Market Cap

4.3B

Sector

Utilities

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$83.85

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWE
CRNX
Founded
1923
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.9B
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
NWE
CRNX
Price
$72.13
$83.85
Analyst Decision
Buy
Strong Buy
Analyst Count
7
8
Target Price
$66.50
$76.75
AVG Volume (30 Days)
421.0K
6.0M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.76%
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
$1,610,559,000.00
$1,039,000.00
Revenue This Year
$8.84
$720.10
Revenue Next Year
$5.31
$184.67
P/E Ratio
$71.18
N/A
Revenue Growth
6.38
N/A
52 Week Low
$51.99
$25.83
52 Week High
$75.18
$84.00

Technical Indicators

Market Signals
Indicator
NWE
CRNX
Relative Strength Index (RSI) 52.81 92.91
Support Level $69.08 $41.42
Resistance Level $74.24 N/A
Average True Range (ATR) 1.54 0.85
MACD 0.12 2.82
Stochastic Oscillator 55.16 99.68

Price Performance

Historical Comparison
NWE
CRNX

About NWE NorthWestern Energy Group Inc.

NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric, which includes the generation, purchase, transmission, and distribution of electricity, and Natural Gas, which includes the production, purchase, transmission, storage, and distribution of natural gas. It uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric segment.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: